BML-259

• Description :

  BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  260.36

• Molecular Formula :

  C14H16N2OS

• Notes :

  Research use only, not for human use.

• Receptor :

  Antifungal|Antiviral

• CAS Number :

  267654-00-2